Synutra International, Inc.  

(Public, NASDAQ:SYUT)   Watch this stock  
Find more results for SYUT
-0.01 (-0.20%)
Nov 25 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.08 - 5.19
52 week 4.45 - 8.15
Open 5.10
Vol / Avg. 51,241.00/53,693.00
Mkt cap 291.66M
P/E 5.90
Div/yield     -
EPS 0.86
Shares 57.19M
Beta 2.08
Inst. own 16%
Feb 8, 2016
Q3 2016 Synutra International Inc Earnings Release (Estimated) Add to calendar
Nov 10, 2015
Q2 2016 Synutra International Inc Earnings Call - Webcast
Nov 9, 2015
Q2 2016 Synutra International Inc Earnings Release
Sep 10, 2015
Synutra International Inc at Rodman & Renshaw Global Investment Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2015
Net profit margin 0.73% 17.40%
Operating margin 14.75% 17.81%
EBITD margin - 19.26%
Return on average assets 0.34% 11.85%
Return on average equity 1.68% 80.24%
Employees 2,700 -
CDP Score - -


15200 Shady Grove Rd Ste 350
ROCKVILLE, MD 20850-6227
United States - Map
+1-301-8403888 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Synutra International, Inc. is an infant formula company in China. The Company is engaged in the production, distribution and sale of dairy-based nutritional products under the Shengyuan or Synutra line of brands. The Company operates through three segments: Nutritional Food, which includes the sale of powdered infant and adult formula products, with brands, including Super, My Angel and Dutch Cow, as well as the sale of prepared foods under the brand of Huiliduo; Nutritional Supplement, which includes the production and sale of nutritional supplements, such as chondroitin sulfate to third-parties and microencapsulated Docosahexanoic Acid and Arachidonic Acid to the nutritional food segment for use in powdered formula production and Other Business, which includes non-core businesses, such as ancillary sales of excess or unusable ingredients and materials to industrial customers, providing genetic diagnostic services for new born babies, and sales of cosmetics to pregnant women.

Officers and directors

Liang Zhang Chairman of the Board, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Ning Cai Chief Financial Officer
Age: 39
Bio & Compensation  - Reuters
Feng Zha Vice President - Human Resources and Administration
Age: 52
Bio & Compensation  - Reuters
Xisen Mu Vice President - Production
Age: 58
Bio & Compensation  - Reuters
Jinrong Chen Independent Director
Age: 56
Bio & Compensation  - Reuters
Lei Lin Independent Director
Age: 48
Bio & Compensation  - Reuters
Donghao Yang Independent Director
Age: 43
Bio & Compensation  - Reuters